Lung cancer remains the leading cause of cancer-related mortality globally. The detection rate of nodules has significantly ...

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-extending combination therapy.